Andere talen Morphic Holding, Inc.

Aandelen

MORF

US61775R1059

Geschatte realtime Cboe BZX Andere beurzen 21:32:58 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
27,94 ^USD	+1,56%		-3,05%	-3,79%

19/03	Morphic Holding benoemt Simon Cooper als Chief Medical Officer	MT
19/03	Morphic Therapeutic benoemt Simon Cooper tot Chief Medical Officer	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ademi LLP Investigates Claims of Securities Fraud against Morphic Holding, Inc.	03/04
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	02/04
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	27/03
Morphic Holding Names Simon Cooper as Chief Medical Officer	19/03
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer	19/03
Morphic Therapeutic Appoints Simon Cooper as Chief Medical Officer	19/03
Morphic to Participate in March Investor Conferences	05/03
Morphic Holding's Full Year 2023 Net Loss Widens, Collaboration Revenue Falls	22/02
Morphic Holding, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023	22/02
North American Morning Briefing : Stock Futures -2-	21/02
Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	11/01
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	11/01
The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	04/01
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Morphic Ethical Equities Fund Buys Back Shares	28/12
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors	01/12
Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors	22/11
Morphic to Present at November Investor Conferences	10/11
Morphic Holding, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Morphic Holding, Inc.

Aandelen

MORF

US61775R1059

Andere talen

Filters